Company / Interest Expense
Glaukos Corp. Interest Expense History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$13.6M
FY2023
5-year range
$13.4M / $13.7M
FY2019-FY2023
Trend
-0.6%
vs FY2022
Sector context
#33 of 40
Health Care
What the data says
Glaukos Corp.'s interest expense of $14M is lower than 82% of companies in the Health Care sector (FY2023). Interest Expense has fluctuated over the past 5 years, ranging from $3M in FY2019 to $14M in FY2020.
Based on SEC 10-K filings.
$14M in FY2023 with a 3-year CAGR of -1.2%.
Remained stable around $14M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -1.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 40This company $13.6M Sector average $332.7M
▼
-95.9% below sector average
Key checks
Key Insights
- 3-year CAGR of -1.2%, indicating a declining trend.
- In FY2023, interest expense decreased 0.6% year-over-year.
- Ranks #33 out of 40 companies in the Health Care sector.
- Peak interest expense was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $13.6M | -0.6% |
| FY2022 | $13.7M | +2.6% |
| FY2021 | $13.4M | -5.3% |
| FY2020 | $14.1M | +450.3% |
| FY2019 | $2.6M | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026